Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT06750458

Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients

Conditions: Glioma, Dapagliflozin (Forxiga), Dexamethasone

Sex: All

Ages: 18 Years – 75 Years

Healthy volunteers: No

Phase: PHASE3

Enrollment: 75

Sponsor: Tanta University

Location: Faculty of pharmacy Tanta university Tanta

Summary

The aim of the study is to compare between the role of dapagliflozin versus dexamethasone in pre-operative management of non-diabetic glioma patients on levetiracetam as anti-seizure drug.

Eligibility Criteria

Inclusion Criteria: * Males \& females. * Age: between 18 and 75 years old. * Pre-operative non-diabetic glioma patients on levetiracetam. • Diagnosis will be confirmed by: * The initial clinical examination. * Magnetic resonance imaging of the brain (MRI) with contrast. Exclusion Criteria: * Age: \> 75 years old, and \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06750458). StuddyBuddy aggregates publicly available trial information.